Hongyang Wang

34.9k total citations · 7 hit papers
486 papers, 22.0k citations indexed

About

Hongyang Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hongyang Wang has authored 486 papers receiving a total of 22.0k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Molecular Biology, 121 papers in Cancer Research and 93 papers in Oncology. Recurrent topics in Hongyang Wang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (46 papers), RNA modifications and cancer (41 papers) and MicroRNA in disease regulation (37 papers). Hongyang Wang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (46 papers), RNA modifications and cancer (41 papers) and MicroRNA in disease regulation (37 papers). Hongyang Wang collaborates with scholars based in China, United States and Hong Kong. Hongyang Wang's co-authors include Lei Chen, Yexiong Tan, Mengchao Wu, Le‐Xing Yu, Jin Ding, Bo Zheng, Yanjing Zhu, Jing Fu, Wen Yang and Liwei Dong and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Hongyang Wang

461 papers receiving 21.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer

2018 779 citations Le‐Xing Yu, Linna Guo et al. profile →
A family of proteins that inhibit signalling through tyrosine kinase receptors

1997 572 citations Hongyang Wang et al. profile →
New knowledge of the mechanisms of sorafenib resistance in liver cancer

2017 530 citations Yanjing Zhu, Bo Zheng et al. profile →
Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing

2020 524 citations Liwei Dong, Xiuliang Cui et al. profile →
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

2020 260 citations Hongyang Wang et al. profile →
M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

2021 174 citations Xinyao Qiu, Shuai Yang et al. Cancer Research profile →
TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer

2024 62 citations Xiuliang Cui, Hongyang Wang et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hongyang Wang	12.2k	6.6k	4.6k	3.6k	3.4k	486	22.0k
Eli Pikarsky	8.8k 0.7×	4.8k 0.7×	5.0k 1.1×	3.6k 1.0×	2.8k 0.8×	135	18.1k
Shusen Zheng	10.2k 0.8×	5.5k 0.8×	4.7k 1.0×	2.3k 0.6×	4.2k 1.3×	914	22.1k
Xin‐Yuan Guan	18.3k 1.5×	8.7k 1.3×	7.9k 1.7×	2.9k 0.8×	1.7k 0.5×	645	28.7k
Daiming Fan	13.4k 1.1×	7.9k 1.2×	4.5k 1.0×	1.4k 0.4×	3.7k 1.1×	573	24.0k
Haiyang Xie	8.1k 0.7×	4.6k 0.7×	3.2k 0.7×	1.9k 0.5×	2.0k 0.6×	449	14.9k
Wen G. Jiang	14.5k 1.2×	5.0k 0.7×	6.4k 1.4×	2.6k 0.7×	1.1k 0.3×	830	25.5k
Sergei I. Grivennikov	8.2k 0.7×	4.7k 0.7×	10.0k 2.2×	8.6k 2.4×	2.6k 0.8×	73	24.3k
Qi Zhang	7.7k 0.6×	4.4k 0.7×	3.8k 0.8×	3.3k 0.9×	1.4k 0.4×	663	16.7k
Hui Y. Lan	16.2k 1.3×	4.9k 0.7×	3.0k 0.7×	7.1k 1.9×	2.7k 0.8×	467	37.4k
William E. Grizzle	14.1k 1.2×	6.4k 1.0×	6.3k 1.4×	3.9k 1.1×	1.6k 0.5×	499	26.2k

Countries citing papers authored by Hongyang Wang

Since Specialization

Citations

This map shows the geographic impact of Hongyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyang Wang more than expected).

Fields of papers citing papers by Hongyang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyang Wang. The network helps show where Hongyang Wang may publish in the future.

Co-authorship network of co-authors of Hongyang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyang Wang. A scholar is included among the top collaborators of Hongyang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyang Wang. Hongyang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hongyang, et al.. (2025). L-arginine synergistic with 5-fluorouracil intervenes in DNA damage repair via the DNA-PKcs/ATM/ATR pathway in hepatocellular carcinoma cells. Acta Biochimica et Biophysica Sinica.

Wang, Hongyang, Zhaoyong Zhang, Zhiying Zhang, et al.. (2023). A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains. SHILAP Revista de lepidopterología. 4(6). e397–e397. 5 indexed citations

Gao, Yanan, Geoffrey J. Markowitz, Jing Fu, et al.. (2021). Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation. Cancer Research. 81(9). 2386–2398. 56 indexed citations

Qiu, Xinyao, Shuai Yang, Shan Wang, et al.. (2021). M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Cancer Research. 81(18). 4778–4793. 174 indexed citations breakdown →

Shi, Donghua, Yao Shi, Ahmed O. Kaseb, et al.. (2020). Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials. Clinical Cancer Research. 26(15). 3979–3989. 254 indexed citations

Sun, Wen, Shichao Li, Li Xu, et al.. (2020). High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma. Clinical Cancer Research. 26(16). 4302–4312. 16 indexed citations

Xiang, Daimin, Wen Sun, Beifang Ning, et al.. (2017). The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut. 67(9). 1704–1715. 181 indexed citations

Markowitz, Geoffrey J., Pengyuan Yang, Jing Fu, et al.. (2016). Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes. Cancer Research. 76(8). 2394–2405. 42 indexed citations

Yin, Jianhua, Rui Pu, Haiguang Xin, et al.. (2015). Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study. Cancer Prevention Research. 8(10). 978–988. 21 indexed citations

10.

Jiang, Feng, Lei Chen, Yingcheng Yang, et al.. (2015). CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling. Cancer Research. 75(7). 1470–1481. 52 indexed citations

11.

Gao, Huiping, Kesang Li, Hong Tu, et al.. (2014). Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma. Clinical Cancer Research. 20(24). 6418–6428. 259 indexed citations

12.

Zhou, Min, Hai Wang, Keke Zhou, et al.. (2013). A Novel EGFR Isoform Confers Increased Invasiveness to Cancer Cells. Cancer Research. 73(23). 7056–7067. 20 indexed citations

13.

Huang, Qiang, Yexiong Tan, Peiyuan Yin, et al.. (2013). Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics. Cancer Research. 73(16). 4992–5002. 342 indexed citations

14.

Zheng, Longyi, Wen Yang, Fuquan Wu, et al.. (2013). Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma. Clinical Cancer Research. 19(19). 5372–5380. 184 indexed citations

15.

Tang, Liang, Yexiong Tan, Bei‐Ge Jiang, et al.. (2013). The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma. Clinical Cancer Research. 19(8). 2014–2024. 51 indexed citations

16.

Lin, Yan, Le‐Xing Yu, He‐Xin Yan, et al.. (2012). Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4. Cancer Prevention Research. 5(9). 1090–1102. 33 indexed citations

17.

Wen, Wen, Jin Ding, Wen Sun, et al.. (2010). Suppression of Cyclin D1 by Hypoxia-Inducible Factor-1 via Direct Mechanism Inhibits the Proliferation and 5-Fluorouracil–Induced Apoptosis of A549 Cells. Cancer Research. 70(5). 2010–2019. 69 indexed citations

18.

Ning, Beifang, Jin Ding, Chuan Yin, et al.. (2010). Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma. Cancer Research. 70(19). 7640–7651. 194 indexed citations

19.

Yin, Jianhua, Hongwei Zhang, Yongchao He, et al.. (2010). Distribution and Hepatocellular Carcinoma–Related Viral Properties of Hepatitis B Virus Genotypes in Mainland China: A Community-Based Study. Cancer Epidemiology Biomarkers & Prevention. 19(3). 777–786. 80 indexed citations

20.

Yang, Wen, He‐Xin Yan, Lei Chen, et al.. (2008). Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells. Cancer Research. 68(11). 4287–4295. 306 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact